Molecular engineering and design of therapeutic antibodies
- 1 August 2008
- journal article
- review article
- Published by Elsevier in Current Opinion in Immunology
- Vol. 20 (4), 460-470
- https://doi.org/10.1016/j.coi.2008.06.012
Abstract
No abstract availableKeywords
This publication has 61 references indexed in Scilit:
- The Intrinsic Contributions of Tyrosine, Serine, Glycine and Arginine to the Affinity and Specificity of AntibodiesJournal of Molecular Biology, 2008
- Reduction of IgG in nonhuman primates by a peptide antagonist of the neonatal Fc receptor FcRnProceedings of the National Academy of Sciences, 2008
- High-throughput Generation of Synthetic Antibodies from Highly Functional Minimalist Phage-displayed LibrariesJournal of Molecular Biology, 2007
- APEx 2-hybrid, a quantitative protein–protein interaction assay for antibody discovery and engineeringProceedings of the National Academy of Sciences, 2007
- Molecular evolution of antibody cross-reactivity for two subtypes of type A botulinum neurotoxinNature Biotechnology, 2006
- Divergent activities of an engineered antibody in murine and human systems have implications for therapeutic antibodiesProceedings of the National Academy of Sciences, 2006
- Characterization of a humanized IgG4 anti-HLA-DR monoclonal antibody that lacks effector cell functions but retains direct antilymphoma activity and increases the potency of rituximabBlood, 2006
- Albumin Binding to FcRn: Distinct from the FcRn−IgG InteractionBiochemistry, 2006
- Engineering the Fc region of immunoglobulin G to modulate in vivo antibody levelsNature Biotechnology, 2005
- Molecular Recognition by a Binary CodeJournal of Molecular Biology, 2005